Cryo-Cell Operating Income 2010-2025 | CCEL

Cryo-Cell operating income from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Cryo-Cell Annual Operating Income
(Millions of US $)
2024 $3
2023 $-12
2022 $4
2021 $4
2020 $8
2019 $5
2018 $5
2017 $5
2016 $0
2015 $3
2014 $2
2013 $2
2012 $-2
2011 $0
2010 $3
2009 $3
Cryo-Cell Quarterly Operating Income
(Millions of US $)
2025-05-31 $1
2025-02-28 $1
2024-11-30 $0
2024-08-31 $1
2024-05-31 $1
2024-02-29 $1
2023-11-30 $-16
2023-08-31 $1
2023-05-31 $1
2023-02-28 $2
2022-11-30 $0
2022-08-31 $1
2022-05-31 $1
2022-02-28 $1
2021-11-30 $-1
2021-08-31 $2
2021-05-31 $2
2021-02-28 $1
2020-11-30 $2
2020-08-31 $2
2020-05-31 $2
2020-02-29 $1
2019-11-30 $2
2019-08-31 $2
2019-05-31 $0
2019-02-28 $1
2018-11-30 $2
2018-08-31 $1
2018-05-31 $1
2018-02-28 $1
2017-11-30 $1
2017-08-31 $1
2017-05-31 $1
2017-02-28 $1
2016-11-30 $0
2016-08-31 $-1
2016-05-31 $1
2016-02-29 $0
2015-11-30 $0
2015-08-31 $1
2015-05-31 $1
2015-02-28 $1
2014-11-30 $0
2014-08-31 $0
2014-05-31 $1
2014-02-28 $1
2013-11-30 $0
2013-08-31 $1
2013-05-31 $0
2013-02-28 $1
2012-11-30 $-1
2012-08-31 $0
2012-05-31 $-1
2012-02-29 $0
2011-11-30 $0
2011-08-31 $-2
2011-05-31 $1
2011-02-28 $1
2010-11-30 $1
2010-08-31 $1
2010-05-31 $1
2010-02-28 $1
2009-11-30 $0
2009-08-31 $1
2009-05-31 $1
2009-02-28 $1
Sector Industry Market Cap Revenue
Medical Medical Services $0.038B $0.032B
CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $147.306B 27.32
CVS Health (CVS) United States $83.088B 10.33
Elevance Health (ELV) United States $65.860B 8.86
Cencora (COR) United States $56.044B 18.67
DiDi Global (DIDIY) China $26.733B 28.40
Labcorp Holdings (LH) United States $22.380B 17.79
Natera (NTRA) United States $21.934B 0.00
BioMerieux (BMXMF) France $17.238B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $15.271B 0.00
ICON (ICLR) Ireland $13.654B 13.14
CochLear (CHEOY) Australia $13.302B 0.00
Medpace Holdings (MEDP) United States $12.903B 34.15
Solventum (SOLV) United States $12.500B 12.90
Viatris (VTRS) United States $11.799B 4.20
Revvity (RVTY) United States $10.214B 18.00
Sonic Healthcare (SKHHY) Australia $9.176B 0.00
Avantor (AVTR) United States $8.631B 12.66
Caris Life Sciences,�Inc (CAI) United States $8.258B 0.00
HealthEquity (HQY) United States $8.040B 35.22
Charles River Laboratories (CRL) United States $7.517B 14.26
Bausch + Lomb (BLCO) Canada $4.874B 32.79
Sotera Health (SHC) United States $4.221B 23.59
Amplifon S.p.A (AMFPF) Italy $3.937B 21.83
BrightSpring Health Services (BTSG) United States $3.848B 29.35
GeneDx Holdings (WGS) United States $3.344B 76.59
Surgery Partners (SGRY) United States $2.946B 37.06
Alignment Healthcare (ALHC) United States $2.899B 0.00
Concentras Parent (CON) United States $2.871B 18.21
Organon (OGN) United States $2.353B 2.56
Premier (PINC) United States $1.978B 15.01
Progyny (PGNY) United States $1.873B 39.60
Ardent Health (ARDT) United States $1.785B 6.89
PACS (PACS) United States $1.705B 0.00
Pediatrix Medical (MD) United States $1.282B 8.56
GoodRx Holdings (GDRX) United States $1.250B 20.59
Teladoc Health (TDOC) United States $1.214B 0.00
Establishment Labs Holdings (ESTA) $0.974B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.965B 0.00
Embecta (EMBC) United States $0.779B 4.56
AMN Healthcare Services Inc (AMN) United States $0.676B 8.36
CareDx (CDNA) United States $0.663B 12.22
Performant Healthcare (PHLT) United States $0.602B 0.00
QDM (QDMI) Hong Kong, SAR China $0.583B 200.00
Nutex Health (NUTX) United States $0.534B 8.08
Omada Health (OMDA) $0.497B 0.00
So-Young (SY) China $0.488B 0.00
InnovAge Holding (INNV) United States $0.485B 0.00
Sonida Senior Living (SNDA) United States $0.480B 0.00
SBC Medicals (SBC) United States $0.470B 0.00
Auna S.A (AUNA) Luxembourg $0.467B 10.52
COMPASS Pathways (CMPS) United Kingdom $0.405B 0.00
Enhabit (EHAB) United States $0.382B 25.13
Agilon Health (AGL) United States $0.369B 0.00
Oncology Institute (TOI) United States $0.367B 0.00
LifeMD (LFMD) United States $0.324B 0.00
Beauty Health (SKIN) United States $0.292B 0.00
Shoulder Innovations (SI) United States $0.200B 0.00
DocGo (DCGO) United States $0.169B 0.00
Ascend Wellness Holdings (AAWH) United States $0.129B 0.00
KindlyMD (NAKA) United States $0.084B 0.00
Sera Prognostics (SERA) United States $0.084B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Biodesix (BDSX) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.048B 0.00
Basel Medical Group (BMGL) Singapore $0.040B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.040B 0.00
ModivCare (MODV) United States $0.033B 0.00
OSR Holdings (OSRH) United States $0.011B 0.00
BioNexus Gene Lab (BGLC) $0.010B 0.00
Intelligent Bio Solutions (INBS) United States $0.010B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
XWELL (XWEL) United States $0.007B 0.00
Pheton Holdings (PTHL) China $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00